News

Track Our News on

2024-01-22

MindRank Founder Zhangming Niu Named in 2023 Forbes China Outstanding Foreign Talent Selection Honoree List

2024-01-19

MindRank and Henlius (2696.HK) Announce Strategic Collaboration for AI-Driven Development of Next-Gen Antibody Drug Conjugates (ADCs) and Anti-Aging Therapy Platform

2023-11-24

Galen Growth | MindRank Features in the HealthTech 250 most promising early-stage Digital Health ventures list for 2023

2023-11-24

MindRank Founder Zhangming Niu Awarded Forbes China 100 Outstanding Overseas Returnees

2023-11-23

MindRank has Nominated Kinase Inhibitors as Preclinical Candidates with the Potential to be Best-in-Class for IND-Enabling Studies

2023-11-06

MindRank Founder Zhangming Niu Named to Hurun China Under40s 2023

2023-11-06

MindRank Nominates a Preclinical Candidate with Dual-Target Capabilities for IND-Enabling Studies, the “First-in-Class” in the DDR Area

2023-10-20

MindRank Awarded “Future Unicorn | The Inaugural Dual 30 AI Ranking of Innovative Companies” by KPMG China

2023-10-18

Journal of Biomolecular Structure and Dynamics | The Binding Mechanism of Failed, in Processing and Succeed Inhibitors Target SARS-CoV-2 Main Protease

2023-10-11

Bioinformatics | An Extensive Benchmark Study on Biomedical Text Generation and Mining with ChatGPT

2023-09-07

MindRank Announces the Commencement of Phase IIa Clinical Study of MDR-001 in China

2023-09-01

MindRank Features in Forbes Asia 100 to Watch 2023 List

2 / 5